Tau is a protein expressed in the cells of the human nervous system. These cells, known as neurons, rely on the stability of this protein to ensure communication between the various regions of the brain and spinal cord. Tau proteins bind to microtubules, which are a type of filamentous protein structure that forms the framework of the cell. Tau functions to maintain the shape and the stability of the microtubules, allowing neurotransmitters to be transported in a rapid and efficient manner. Mutations of the Tau protein can lead to neurodegenerative diseases, such as Alzheimer's and frontotemporal dementia, which involve the progressive deterioration of the nervous system. In these conditions, increased amounts of abnormally shaped tau proteins form aggregates in the brain, leading to the breakdown of neuronal connections and impairing communication between brain regions. The tau protein is also involved in the body's defense system. In response to cellular stress, Tau proteins can act as an anti-apoptotic mechanism to protect cells from apoptosis. In addition, tau proteins help to reduce inflammation and promote neuron survival by regulating the release of pro-inflammatory cytokines. Tau proteins have also been suggested to function as regulatory proteins in the brain. Studies have indicated that Tau helps ensure proper functioning of synaptic transmission and neuronal networks, and may play a role in memory formation and recall. Additionally, tau proteins appear to be involved in the maintenance of normal neuronal homeostasis. Overall, the Tau protein performs a wide variety of functions to ensure communication between neurons in the brain and prevent the development of neurodegenerative diseases. Recent advances in research have suggested an increased role of tau proteins in regulation of neuronal functioning and homeostasis. Further research into the regulatory functions of tau proteins will lend more understanding of the normal functioning of neurons and the development of neurological diseases.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States